Hypoxia Inducible Factors
Hypoxia Inducible Factors (HIFs) are transcription factors that are activated in response to decreased oxygen availability in the cellular environment. They influence cell metabolism, cell survival and angiogenesis to maintain biological homeostasis. The HIF family is made up of α subunits (HIF-1, HIF-2 and HIF-3) and a constitutively expressed β subunit (ARNT; also known as Aryl hydrocarbon Receptor Nuclear Translocator).
The best characterized hypoxia response pathway is mediated by hypoxia-inducible factor-1 (HIF-1). In normoxia (when oxygen is present), prolyl hydroxylases 1-3 (PHD1-3) control the degradation of HIF-1α through hydroxylating several proline residues located at the oxygen-dependent degradation domain of HIF-1α. Hydroxylated HIF-1α interacts with von Hippel-Lindau (VHL) protein targeting it for proteasomal degradation. In hypoxia (the absence of oxygen), the HIFα subunit is stabilized due to the lack of oxygen; it translocates to the nucleus, where it dimerizes with the nuclear HIF-1β (ARNT) to form the transcriptionally active HIF. By interacting with the co-activator CBP/p300, HIF-1 activates transcription of target genes that fall into four major categories: glucose transporters and glycolysis, angiogenesis, survival and proliferation, as well as invasion and metastasis. HIF-2α appears to also be regulated by this mechanism; however, HIF-3α may have a different role in the inhibition of HIF-1α and HIF-2α. HIF thereby regulates gene expression through interaction with specific hypoxic response elements (HRE) on hypoxic responsive genes.
HIF-1α has been shown to play an important role in the tumor response to hypoxia. Hypoxia increases tumor glycolysis, angiogenesis and other survival responses, as well as invasion and metastasis, by activating relevant genes through HIFs. HIF-1α activity in tumors has been correlated with increased angiogenesis and aggressive tumor growth, and therefore has led to current interest in HIF-1α as a pharmacological target within cancer research.
Hypoxia also induces epigenetic changes in chromatin architecture and DNA methylation status, and HIF-1α has also been suggested to regulate several histone demethylase enzymes. View all products for Hypoxia Inducible Factors »
|Gene||Species||Gene Symbol||Gene Accession No.||Protein Accession No.|
|Hypoxia Inducible Factor 1, alpha subunit||Human||HIF1A||NM_001530||Q16665|
|Hypoxia Inducible Factor 1, alpha subunit inhibitor||Human||HIF1AN||NM_017902||Q9NWT6|
|View all Hypoxia Inducible Factor Gene Data »|
Literature for Hypoxia Inducible Factors
A collection of over 750 products for cancer research, the guide includes research tools for the study of:
- Cancer Metabolism
- Epigenetics in Cancer
- Receptor Signaling
- Cell Cycle and DNA Damage Repair
- Invasion and Metastasis
Written by Yongping Crawford and Napoleone Ferrara, this poster highlights major targets for antiangiogenic therapy, namely tumor- and stromal cell-derived pathways. Intrinsic and acquired resistance are described; antiangiogenic therapies targeting the VEGF pathway are also summarized. Compounds available from Tocris are listed.Request copy | View all posters
Find multiple products by catalog number
October 30 - November 3, 2016
Boston, MA, USA